Summit Therapeutics (NASDAQ:SMMT) Coverage Initiated at Evercore ISI
Evercore ISI initiated coverage on shares of Summit Therapeutics (NASDAQ:SMMT – Free Report) in a research note issued to investors on Wednesday morning, Marketbeat.com reports. The firm issued an outperform rating and a $30.00 price objective on the stock. Other equities research analysts have also issued reports about the company. Truist Financial started coverage on […]
Evercore ISI initiated coverage on shares of Summit Therapeutics (NASDAQ:SMMT – Free Report) in a research note issued to investors on Wednesday morning, Marketbeat.com reports. The firm issued an outperform rating and a $30.00 price objective on the stock. Other equities research analysts have also issued reports about the company. Truist Financial started coverage on […]
